Published in
Elsevier, European Journal of Cancer, (147), p. 1-12, 2021
DOI: 10.1016/j.ejca.2021.01.010
Links
Tools
Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma
Journal article published in 2021 by
Paul M. J. Clement,
Linda Dirven 
,
Marica Eoli,
Juan M. Sepulveda-Sanchez,
Annemiek M. E. Walenkamp,
Jean S. Frenel,
Enrico Franceschi ,
Michael Weller,
Olivier Chinot,
Filip Y. F. L. De Vos,
Nicolas Whenham,
Paul Sanghera,
Jim Looman,
Madan G. Kundu,
Jan Peter de Geus
and other authors.
,
Marica Eoli,
Juan M. Sepulveda-Sanchez,
Annemiek M. E. Walenkamp,
Jean S. Frenel,
Enrico Franceschi ,
Michael Weller,
Olivier Chinot,
Filip Y. F. L. De Vos,
Nicolas Whenham,
Paul Sanghera,
Jim Looman,
Madan G. Kundu,
Jan Peter de Geus
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 